CalciMedica Inc. ("CalciMedica" or the "Company") , a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and ...
Mechanisms and Frontiers of Treatment for Diabetes-Related Epilepsy. Journal of Biosciences and Medicines, 14, 57-73. doi: 10.4236/jbm.2026.143006 . Diabetes mellitus (DM) is a metabolic disease ...
Managing the money supply of a modern economy is a dirty job, but somebody has to do it. For some 110 years, we have had an operating central bank, the Federal Reserve system, to do that. It could ...
ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a Fortune 500 company and one of the largest operators of convenience stores and wholesalers of fuel in the United States, today announced ...
TKO Group Holdings, Inc. ("TKO" or the "Company") today announced financial results for its fourth quarter and full year ended December 31, 2025. "TKO's 2025 results reflect meaningful momentum across ...
Delivered strong full year 2025 results Completed Initial Public Offering Introduced full year 2026 guidance Fourth quarter net sales of $7.8 ...
Record total revenues of $211.6 million and $719.0 million in the fourth quarter and full year 2025, a 21% and 9% increase compared to same periods last year.Combined revenues of the Company's four ...
The Corolla Cross has hit its midlife facelift, featuring updates for the first time since its launch in 2022. But, with the car sporting the same tech underneath, how’s it holding up in 2025?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results